• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病中的非持续性室性心动过速:年轻患者猝死风险的独立标志物。

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.

作者信息

Monserrat Lorenzo, Elliott Perry M, Gimeno Juan R, Sharma Sanjay, Penas-Lado Manuel, McKenna William J

机构信息

Service of Cardiology, Juan Canalejo Hospital, A Coruña, Spain.

出版信息

J Am Coll Cardiol. 2003 Sep 3;42(5):873-9. doi: 10.1016/s0735-1097(03)00827-1.

DOI:10.1016/s0735-1097(03)00827-1
PMID:12957435
Abstract

OBJECTIVES

The aim of this study was to examine the characteristics of non-sustained ventricular tachycardia (NSVT) episodes during Holter monitoring and to determine their relationship to age and prognosis.

BACKGROUND

It has been suggested that NSVT is only of prognostic importance in patients with hypertrophic cardiomyopathy (HCM) when repetitive, prolonged, or associated with symptoms.

METHODS

We studied 531 patients with HCM (323 male, 39 +/- 15 years). All underwent ambulatory electrocardiogram monitoring (41 +/- 11 h).

RESULTS

A total of 104 patients (19.6%) had NSVT. The proportion of patients with NSVT increased with age (p = 0.008). Maximum left ventricular wall thickness and left atrial size were greater in patients with NSVT. Mean follow-up was 70 +/- 40 months. Sixty-eight patients died, 32 from sudden cardiac death (SCD). Twenty-one patients received an implantable cardioverter defibrillator (ICD). There were four appropriate ICD discharges. In patients < or =30 years (but not >30), five-year freedom from sudden death was lower in those with NSVT (77.6% [95% confidence interval (CI): 59.8 to 95.4] vs. 94.1% [95% CI: 90.2 to 98.0]; p = 0.003). There was no relation between the duration, frequency, or rate of NSVT runs and prognosis at any age. The odds ratio of sudden death in patients < or =30 years of age with NSVT was 4.35 (95% CI: 1.54 to 12.28; p = 0.006) compared with 2.16 (95% CI: 0.82 to 5.69; p = 0.1) in patients >30 years of age.

CONCLUSIONS

Non-sustained ventricular tachycardia is associated with a substantial increase in sudden death risk in young patients with HCM. A relation between the frequency, duration, and rate of NSVT episodes could not be demonstrated.

摘要

目的

本研究旨在探讨动态心电图监测期间非持续性室性心动过速(NSVT)发作的特征,并确定其与年龄及预后的关系。

背景

有研究表明,NSVT仅在肥厚型心肌病(HCM)患者中,当发作反复、持续时间长或伴有症状时才具有预后意义。

方法

我们研究了531例HCM患者(男性323例,年龄39±15岁)。所有患者均接受动态心电图监测(41±11小时)。

结果

共有104例患者(19.6%)发生NSVT。发生NSVT的患者比例随年龄增加而升高(p = 0.008)。NSVT患者的最大左心室壁厚度和左心房大小更大。平均随访时间为70±40个月。68例患者死亡,32例死于心源性猝死(SCD)。21例患者接受了植入式心律转复除颤器(ICD)。有4次ICD恰当放电。在年龄≤30岁(而非>30岁)的患者中,发生NSVT者的5年无猝死生存率较低(77.6%[95%置信区间(CI):59.8至95.4] vs. 94.1%[95% CI:90.2至98.0];p = 0.003)。NSVT发作的持续时间、频率或心率与任何年龄的预后均无关联。年龄≤30岁的NSVT患者心源性猝死的比值比为4.35(95% CI:1.54至12.28;p = 0.006),而年龄>30岁的患者为2.16(95% CI:0.82至5.69;p = 0.1)。

结论

非持续性室性心动过速与年轻HCM患者的心源性猝死风险显著增加相关。未证实NSVT发作的频率、持续时间和心率之间存在关联。

相似文献

1
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.肥厚型心肌病中的非持续性室性心动过速:年轻患者猝死风险的独立标志物。
J Am Coll Cardiol. 2003 Sep 3;42(5):873-9. doi: 10.1016/s0735-1097(03)00827-1.
2
Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者心脏磁共振成像显示的弥漫性心室纤维化与室性心动过速相关。
J Cardiovasc Electrophysiol. 2016 May;27(5):571-80. doi: 10.1111/jce.12948. Epub 2016 Mar 14.
3
Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.非持续性室性心动过速在肥厚型心肌病中的预后价值及胺碘酮治疗的潜在作用:在未经选择的非转诊患者群体中的评估
Heart. 1998 Apr;79(4):331-6. doi: 10.1136/hrt.79.4.331.
4
Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病高危患者非持续性室性心动过速的预后意义
Circ Arrhythm Electrophysiol. 2017 Mar;10(3). doi: 10.1161/CIRCEP.116.004604.
5
Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.运动诱发的室性心律失常与肥厚型心肌病患者心源性猝死的风险。
Eur Heart J. 2009 Nov;30(21):2599-605. doi: 10.1093/eurheartj/ehp327. Epub 2009 Aug 17.
6
Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.肥厚型心肌病风险分层中通过设备快速检测到的非持续性室性心动过速
Pacing Clin Electrophysiol. 2016 Jul;39(7):642-51. doi: 10.1111/pace.12861. Epub 2016 May 4.
7
Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia.肥厚型心肌病患者的纵向左心室应变:与非持续性室性心动过速的相关性
Echocardiography. 2011 Aug;28(7):709-14. doi: 10.1111/j.1540-8175.2011.01427.x. Epub 2011 May 12.
8
Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.非持续性室性心动过速作为特发性扩张型心肌病患者猝死的预测指标。胺碘酮治疗的作用。
G Ital Cardiol. 1999 May;29(5):514-23.
9
Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.植入式心脏复律除颤器记录的非持续性室性心动过速对肥厚型心肌病患者的临床影响。
J Cardiovasc Electrophysiol. 2014 Nov;25(11):1180-7. doi: 10.1111/jce.12492. Epub 2014 Aug 27.
10
The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.肥厚型心肌病患者延迟钆增强磁共振与非持续室性心动过速负荷的关系:一项延迟对比增强磁共振研究。
J Cardiovasc Electrophysiol. 2019 May;30(5):651-657. doi: 10.1111/jce.13855. Epub 2019 Feb 2.

引用本文的文献

1
Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging for non-sustained ventricular tachycardia and sudden cardiac death in hypertrophic cardiomyopathy: a meta-analysis.钆延迟强化在心脏磁共振成像中对肥厚型心肌病非持续性室性心动过速和心源性猝死的预后价值:一项荟萃分析。
Eur Radiol. 2025 Aug 20. doi: 10.1007/s00330-025-11961-y.
2
Cardiac Magnetic Resonance Imaging and Arrhythmic Risk Stratification in Cardiomyopathies.心肌病的心脏磁共振成像与心律失常风险分层
J Clin Med. 2025 Jul 11;14(14):4922. doi: 10.3390/jcm14144922.
3
Non-sustained Ventricular Tachycardia and Hypertrophic Cardiomyopathy: When to Consider it as a Risk Factor for Sudden Death and Total Mortality?
非持续性室性心动过速与肥厚型心肌病:何时应将其视为猝死和总死亡率的危险因素?
Arq Bras Cardiol. 2025 Jun 16;122(5):e20250233. doi: 10.36660/abc.20250233. eCollection 2025.
4
Prognostic Value of Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy in a Brazilian Cohort: Comparison with World Literature.非持续性室性心动过速在巴西肥厚型心肌病队列中的预后价值:与世界文献的比较
Arq Bras Cardiol. 2025 Apr;122(5):e20240399. doi: 10.36660/abc.20240399.
5
Sudden cardiac death in hyperthrophic cardiomyopathy: Comparison of predictive models.肥厚型心肌病患者的心源性猝死:预测模型比较
Tunis Med. 2025 Feb 5;103(2):264-269. doi: 10.62438/tunismed.v103i2.4779.
6
The Prognostic Implication of Late Gadolinium Enhancement Quantification and Syncope in Hypertrophic Cardiomyopathy.肥厚型心肌病中晚期钆增强定量及晕厥的预后意义
J Clin Med. 2025 Mar 6;14(5):1781. doi: 10.3390/jcm14051781.
7
Echocardiography and Heart Failure: An Echocardiographic Decision Aid for the Diagnosis and Management of Cardiomyopathies.超声心动图与心力衰竭:心肌病诊断与管理的超声心动图决策辅助工具
Curr Cardiol Rep. 2025 Feb 28;27(1):64. doi: 10.1007/s11886-025-02194-y.
8
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
9
Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy.肥厚型心肌病患者植入式心律转复除颤器的使用情况及预后的全球和时间趋势
Circ Arrhythm Electrophysiol. 2025 Feb;18(2):e013479. doi: 10.1161/CIRCEP.124.013479. Epub 2025 Feb 3.
10
Cardiomyopathy and Sudden Cardiac Death: Bridging Clinical Practice with Cutting-Edge Research.心肌病与心源性猝死:将临床实践与前沿研究相衔接
Biomedicines. 2024 Jul 18;12(7):1602. doi: 10.3390/biomedicines12071602.